Quick Answer
Shuttle Pharmaceuticals Holdings, Inc. reported Shares Outstanding of 2.02 million shares for fiscal year 2025.
Shuttle Pharmaceuticals Holdings, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.02M | +1140.8% |
| 2024 | 163,093 | -91.9% |
| 2023 | 2.01M | -85.2% |
| 2022 | 13.60M | +46.1% |
| 2021 | 9.31M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.24M | -58.1% | +15.4% |
| June 30, 2025 | 1.07M | -49.2% | -83.2% |
| March 31, 2025 | 6.38M | -62.1% | +3813.5% |
| December 31, 2024 | 163,093 | -91.9% | -94.5% |
| September 30, 2024 | 2.95M | -81.6% | +39.9% |
| June 30, 2024 | 2.11M | -86.4% | -87.5% |
| March 31, 2024 | 16.82M | +23.2% | +737.4% |
| December 31, 2023 | 2.01M | -85.2% | -87.4% |
- Shuttle Pharmaceuticals Holdings, Inc. showed an increase of +1140.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Shuttle Pharmaceuticals Holdings, Inc.’s shares outstanding has declined by 78.3% (from 9.31 million shares to 2.02 million shares).
- The most recent figure is from Shuttle Pharmaceuticals Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: